Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs van Luin

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
AIDS (London, England)|March 20, 2010
Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavirMatthijs van Luin, Marchina E Van der Ende, Clemens Richter, et al.
Clinical Pharmacokinetics|April 6, 2024
Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous AdministrationJulia E M van Dommelen, Heleen Grootjans, Esther V Uijtendaal, et al.
Therapeutic Drug Monitoring|April 29, 2025
Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI CategoriesMart P Kicken, Corine Bethlehem, Karin Beunen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 9, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapyRoselie Achten, Judith Thijs, Marlot van der Wal, et al.
Clinical and Translational Allergy|January 27, 2023
High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface diseaseRoselie Achten, Judith Thijs, Marlot van der Wal, et al.
Alimentary Pharmacology & Therapeutics|May 17, 2019
Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapiesMelek Simsek, Debbie S Deben, Carmen S Horjus, et al.
Viruses|February 24, 2024
Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based RegimenArjen J Stam, Ninée V E J Buchholtz, Wouter F W Bierman, et al.
AIDS (London, England)|September 13, 2023
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infectionPien M van Paassen, Lisa van Pul, Karlijn van der Straten, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
AIDS (London, England)|March 20, 2010
Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavirMatthijs van Luin, Marchina E Van der Ende, Clemens Richter, et al.
Clinical Pharmacokinetics|April 6, 2024
Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous AdministrationJulia E M van Dommelen, Heleen Grootjans, Esther V Uijtendaal, et al.
Therapeutic Drug Monitoring|April 29, 2025
Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI CategoriesMart P Kicken, Corine Bethlehem, Karin Beunen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 9, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapyRoselie Achten, Judith Thijs, Marlot van der Wal, et al.
Clinical and Translational Allergy|January 27, 2023
High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface diseaseRoselie Achten, Judith Thijs, Marlot van der Wal, et al.
Alimentary Pharmacology & Therapeutics|May 17, 2019
Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapiesMelek Simsek, Debbie S Deben, Carmen S Horjus, et al.
Viruses|February 24, 2024
Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based RegimenArjen J Stam, Ninée V E J Buchholtz, Wouter F W Bierman, et al.
AIDS (London, England)|September 13, 2023
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infectionPien M van Paassen, Lisa van Pul, Karlijn van der Straten, et al.
Pageof 4